div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=document-pharma-nledica-vol-29-no-1-2011-95-ph-z-ckd-ckd-mbd-zut-intacthtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: · Pharma Nledica Vol 29 NO 1 2011 95 pH Z CKD CKD- MBD žut intact PTH iPTH C žqfÉ Caffi84mgdL P 46mgdL GFR 120 mLÐ 105 402 mg % 400 100 co mg % 998 04 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader030fdocumentsusreader030viewer20220407025d66f20c88c99356368bb1bfhtml5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=document-pharma-nledica-vol-29-no-1-2011-95-ph-z-ckd-ckd-mbd-zut-intacthtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: · Pharma Nledica Vol 29 NO 1 2011 95 pH Z CKD CKD- MBD žut intact PTH iPTH C žqfÉ Caffi84mgdL P 46mgdL GFR 120 mLÐ 105 402 mg % 400 100 co mg % 998 04 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader030fdocumentsusreader030viewer20220407025d66f20c88c99356368bb1bfhtml5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=document-pharma-nledica-vol-29-no-1-2011-95-ph-z-ckd-ckd-mbd-zut-intacthtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: · Pharma Nledica Vol 29 NO 1 2011 95 pH Z CKD CKD- MBD žut intact PTH iPTH C žqfÉ Caffi84mgdL P 46mgdL GFR 120 mLÐ 105 402 mg % 400 100 co mg % 998 04 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader030fdocumentsusreader030viewer20220407025d66f20c88c99356368bb1bfhtml5thumbnails3jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage...